In the 2018 legislative session, Mississippi introduced several bills to improve price transparency and cost containment for prescription drugs. While most failed to pass, the legislature passed the Prescription Drug Consumer Affordable Alternative Payment Options Act (HB 709), which allows pharmacists to provide patients with information about affordable alternatives of drugs.


The State Database

The Source tracks state activities impacting healthcare price and competition in both legislation and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare. We currently cover bills from 2017-2019 and key statutes from each state. Search the database for specific bills, statutes or cases by using keyword, key issue category, and/or jurisdiction.

*Note: 2019 legislative session updates are currently in progress. Check back weekly for updates. 

Filter by Key Issues and Year

Filter by Key Issues and Year

Filter by Key Issue

Additional Resources


Mississippi’s current legislative term runs from 1/8/2019 – 4/8/2019. Mississippi’s next legislative term will begin in 2020.


The State of Mississippi fiscal year runs from July 1 through June 30. Mississippi enacted its FY 2018 Budget in the 2017 regular legislative session. To view Mississippi’s Department of Health FY 2018 spending plan, click here.


  • Mississippi was one of 16 states to file an amicus brief supporting the FTC’s winning position in the Ninth Circuit appeal of St. Luke’s Health Care Sys. v. FTC, No. 14-35173 (March 7, 2014), decided February 10, 2015. The States’ brief stated that the acceleration of health care costs due to the growth of large health care provider systems had become a matter of grave concern for the states.